Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126367171 | 12636717 | 1 | I | 20160705 | 20160802 | 20160809 | 20160809 | EXP | FR-UCBSA-2016029470 | UCB | 54.61 | YR | F | Y | 0.00000 | 20160809 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126367171 | 12636717 | 1 | PS | KEPPRA | LEVETIRACETAM | 1 | Oral | 750 MG, 2X/DAY (BID) | U | U | 21035 | 750 | MG | FILM-COATED TABLET | BID | ||||
| 126367171 | 12636717 | 2 | SS | Paroxetine hcl | PAROXETINE HYDROCHLORIDE | 1 | Oral | UNK | U | U | 0 | ||||||||
| 126367171 | 12636717 | 3 | SS | Gardenal | PHENOBARBITAL | 1 | Oral | UNKNOWN DOSE | U | U | 0 | ||||||||
| 126367171 | 12636717 | 4 | SS | Di-hydan | PHENYTOIN | 1 | Oral | 100 MG, 2X/DAY (BID) | U | U | 0 | 100 | MG | TABLET | BID | ||||
| 126367171 | 12636717 | 5 | SS | Urbanyl | CLOBAZAM | 1 | Oral | 10 MG 3/DAY | U | U | 0 | ||||||||
| 126367171 | 12636717 | 6 | SS | HALDOL | HALOPERIDOL | 1 | Oral | UNK | U | U | 0 | ||||||||
| 126367171 | 12636717 | 7 | SS | Stilnox | ZOLPIDEM TARTRATE | 1 | 10 MG, ONCE DAILY (QD) | U | U | 0 | 10 | MG | FILM-COATED TABLET | QD | |||||
| 126367171 | 12636717 | 8 | C | Amlor | AMLODIPINE BESYLATE | 1 | 10 MG DAILY | U | 0 | ||||||||||
| 126367171 | 12636717 | 9 | C | Loperamide | LOPERAMIDE | 1 | U | 0 | |||||||||||
| 126367171 | 12636717 | 10 | C | Levothyrox | LEVOTHYROXINE | 1 | 50 MICRO GRAM IN THE MORNING | U | 0 | 50 | UG | QD | |||||||
| 126367171 | 12636717 | 11 | C | Diffu k | POTASSIUM CHLORIDE | 1 | 1 DF, 3X/DAY (TID) | U | 0 | 1 | DF | CAPSULE | TID | ||||||
| 126367171 | 12636717 | 12 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | 10 MG, ONCE DAILY (QD) IN THE MORNING | U | 0 | 10 | MG | QD | |||||||
| 126367171 | 12636717 | 13 | C | Inexium | ESOMEPRAZOLE | 1 | 40 MG, ONCE DAILY (QD) IN THE EVENING | U | 0 | 40 | MG | QD | |||||||
| 126367171 | 12636717 | 14 | C | FOSAVANCE | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | 70 MG, WEEKLY (QW) | U | 0 | 70 | MG | /wk | |||||||
| 126367171 | 12636717 | 15 | C | Metoject | METHOTREXATE SODIUM | 1 | 15 MG 1 SYRINGE, WEEKLY (QW) | U | 0 | /wk | |||||||||
| 126367171 | 12636717 | 16 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | 0.6 ML/DAY | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126367171 | 12636717 | 1 | Product used for unknown indication |
| 126367171 | 12636717 | 2 | Product used for unknown indication |
| 126367171 | 12636717 | 3 | Product used for unknown indication |
| 126367171 | 12636717 | 4 | Product used for unknown indication |
| 126367171 | 12636717 | 5 | Product used for unknown indication |
| 126367171 | 12636717 | 6 | Product used for unknown indication |
| 126367171 | 12636717 | 7 | Product used for unknown indication |
| 126367171 | 12636717 | 8 | Product used for unknown indication |
| 126367171 | 12636717 | 9 | Product used for unknown indication |
| 126367171 | 12636717 | 10 | Product used for unknown indication |
| 126367171 | 12636717 | 11 | Product used for unknown indication |
| 126367171 | 12636717 | 12 | Product used for unknown indication |
| 126367171 | 12636717 | 13 | Product used for unknown indication |
| 126367171 | 12636717 | 14 | Product used for unknown indication |
| 126367171 | 12636717 | 15 | Product used for unknown indication |
| 126367171 | 12636717 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126367171 | 12636717 | OT |
| 126367171 | 12636717 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126367171 | 12636717 | Brain oedema | |
| 126367171 | 12636717 | Bronchial obstruction | |
| 126367171 | 12636717 | Cardio-respiratory arrest | |
| 126367171 | 12636717 | Coma | |
| 126367171 | 12636717 | Hypoxic-ischaemic encephalopathy | |
| 126367171 | 12636717 | Intracranial pressure increased | |
| 126367171 | 12636717 | Mydriasis | |
| 126367171 | 12636717 | Pupils unequal | |
| 126367171 | 12636717 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |